Structural Basis for the Altered Drug Sensitivities of Non-Small Cell Lung Cancer-Associated Mutants of Human Epidermal Growth Factor Receptor

Oncogene - United Kingdom
doi 10.1038/onc.2012.21
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Role of Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer

Dicle Medical Journal / Dicle Tip Dergisi
2015English

Somatic Mutations of the Epidermal Growth Factor Receptor and Non-Small-Cell Lung Cancer

Journal of Medical Genetics
Genetics
2006English

Management of Brain Metastases in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

Enhancement of Epidermal Growth Factor Receptor-Degradation Pathway in Acquired Gefitinib-Resistant Human Non-Small Cell Lung Cancer Cell Lines

The Showa University Journal of Medical Sciences
2004English

Combining Chemotherapy With Epidermal Growth Factor Receptor Inhibition in Advanced Non-Small Cell Lung Cancer

Therapeutic Advances in Medical Oncology
Oncology
2012English

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non–Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor

JAMA - Journal of the American Medical Association
Medicine
2014English

Epidermal Growth Factor Receptor Status and Notch Inhibition in Non-Small Cell Lung Cancer Cells

Journal of Biomedical Science
Cell BiologyPharmacologyBiochemistryEndocrinologyClinical BiochemistryMolecular BiologyMedicineMetabolismDiabetes
2015English

Association of Epidermal Growth Factor Receptor Mutations With Metastatic Presentations in Non-Small Cell Lung Cancer

ISRN Oncology
2011English

The Treatment of Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy